Law Firm Brower Piven Announces Investigation of Omthera Pharmaceuticals, Inc. Proposed Buyout
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Omthera Pharmaceuticals, Inc. ("Omthera" or the "Company") (NAS: OMTH) and other violations of state law by the board of directors of Omthera relating to the proposed buyout of the Company by AstraZeneca PLC. The firm's investigation seeks to determine, among other things, whether the board of directors of Omthera breached their fiduciary duties by failing to maximize shareholder value.
According to the press release announcing the proposed buyout, Omthera shareholders will receive $12.70 per share in cash for each share of Omthera common stock they own. In addition to the cash payment, each Omthera stockholder will receive one Contingent Value Right of up to approximately $4.70 for each share they own, equating to $120 million, if specified milestones related to Epanova are achieved, or if a milestone related to global net sales is achieved.
If you currently own common stock of Omthera and would like to learn more about the investigation being conducted by Brower Piven, you may email or call Brower Piven, who will, without obligation or cost to you, attempt to answer your questions. You may contact Brower Piven by email at email@example.com, by calling (410) 415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and other class action cases of over 60 years.
Brower Piven, A Professional Corporation
Charles J. Piven, (410) 415-6616
KEYWORDS: United States North America District of Columbia Maryland
The article Law Firm Brower Piven Announces Investigation of Omthera Pharmaceuticals, Inc. Proposed Buyout originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.